- Category: HIV Treatment
- Published on Friday, 28 February 2014 00:00
- Written by HIVandHepatitis.com
The 21st Conference on Retroviruses and Opportunistic Infections (CROI 2014) will take place next week, March 3-6, at the Hynes Convention Center in Boston. HIVandHepatitis.com will be on site all week to bring you the latest news coverage about HIV, hepatitis C, and related topics.
This year's conference -- the major U.S. annual scientific meeting on HIV/AIDS -- is being run for the first time by the new CROI Foundation, under the auspices of the International Antiviral Society-USA (IAS-USA). CROI 2014 is expected to draw some 4000 researchers, clinicians, caregivers, advocates, and members of the media.
As always, the conference will cover advances in the field of HIV, including new antiretroviral drugs and treatment strategies, management of side effects and associated conditions, and prevention, reflecting the recent emphasis on treatment as prevention and pre-exposure prophylaxis (PrEP). Researchers will also provide updates about advances and setbacks in the search for a cure for HIV, including early treatment of infants and bone marrow transplants.
Following the trend of recent years, this year's meeting will again feature a major emphasis on hepatitis C and HIV/HCV coinfection, including new data from clinical trials of direct-acting agents used in interferon-free combination regimens.
The CROI 2014 program is now available online at www.croi2014.org/scientific-program/program-at-a-glance. Abstracts and selected presentations will be available soon on the conference website at www.croi2014.org.
Look for reports and videos from HIVandHepatitis.com and our content partners at NAM/Aidsmap.com starting next Tuesday. Sign up for our newsletter to receive the latest headlines via e-mail and follow us on Twitter @HIVandHepatitis.
21st Conference on Retroviruses and Opportunistic Infections. www.croi2014.org.